Table 2—

Cardiovascular risks related to the dichotomous diagnosis of the metabolic syndrome and to its single components

ATPIII categoryIDF categoryContinuous variable
Diagnosis of the metabolic syndrome
    Model 11.745 (1.255–2.427); P = 0.0011.189 (0.859–1.646); P = 0.297
    Model 21.578 (1.114–2.234); P = 0.0101.102 (0.791–1.534); P = 0.566
    Model 31.576 (1.099–2.258); P = 0.0131.064 (0.755–1.500); P = 0.723
Waist circumference
    Model 10.981 (0.679–1.417); P = 0.9170.889 (0.640–1.234); P = 0.4821.107 (0.904–1.355); P = 0.327
    Model 20.925 (0.639–1.341); P = 0.6820.853 (0.613–1.186); P = 0.3441.060 (0.864–1.299); P = 0.578
    Model 30.961 (0.658–1.404); P = 0.8380.831 (0.593–1.165); P = 0.2831.109 (0.894–1.376); P = 0.345
Blood pressure*
    Model 11.389 (0.967–1.995); P = 0.0751.389 (0.920–2.097); P = 0.1181.181 (0.992–1.406); P = 0.062
    Model 21.336 (0.929–1.922); P = 0.1181.317 (0.870–1.993); P = 0.1931.171 (0.983–1.396); P = 0.078
    Model 31.345 (0.927–1.950); P = 0.1191.302 (0.841–2.016); P = 0.2361.174 (0.983–1.401); P = 0.076
Triglycerides
    Model 11.767 (1.266–2.467); P = 0.0011.699 (1.217–2.372); P = 0.0021.227 (1.090–1.382); P = 0.001
    Model 21.689 (1.208–2.636); P = 0.0021.630 (1.166–2.280); P = 0.0041.188 (1.051–1.343); P = 0.006
    Model 31.639 (1.163–2.309); P = 0.0051.617 (1.144–2.288); P = 0.0071.174 (1.033.10.334); P = 0.014
HDL cholesterol
    Model 11.963 (1.398–2.756); P < 0.0011.963 (1.398–2.756); P < 0.0010.722 (0.579–0.900); P = 0.004
    Model 21.852 (1.314–2.611); P < 0.0011.852 (1.314–2.611); P < 0.0010.755 (0.605–0.942); P = 0.013
    Model 31.838 (1.293–2.612); P = 0.0011.838 (1.293–2.612); P = 0.0010.765 (0.610–0.960); P = 0.021
Glucose
    Model 11.524 (1.102–2.109); P = 0.0111.547 (1.074–2.229); P = 0.0191.176 (1.027–1.348); P = 0.019
    Model 21.304 (0.898–1.893); P = 0.1631.336 (0.896–1.992); P = 0.1551.055 (0.879–1.266); P = 0.565
    Model 31.279 (0.874–1.871); P = 0.2051.296 (0.866–1.938); P = 0.2071.041 (0.858–1.262); P = 0.648
  • Data are adjusted HR (95% CI). Model 1 adjusts for age, sex, smoking, LDL cholesterol, and CAD at baseline. Model 2 adjusts for the covariates included in model 1 and additionally for type 2 diabetes. Model 3 adjusts for the covariates included in model 2 and additionally for treatment with medications (statins, fibrates, ACE inhibitors, angiotensin II inhibitors, aspirin, β-blockers, diuretics, and calcium antagonists).

  • *

    * Standardized adjusted HRs for the continuous variable are given for systolic blood pressure; for diastolic blood pressure, the respective standardized adjusted HRs were 1.068 (0.897–1.272), P = 0.462, in model 1; 1.070 (0.901–1.270), P = 0.443, in model 2; and 1.075 (0.906–1.276), P = 0.409, in model 3.